ClinVar Genomic variation as it relates to human health
NM_032977.4(CASP10):c.1216A>T (p.Ile406Leu)
The aggregate germline classification for this variant, typically for a monogenic or Mendelian disorder as in the ACMG/AMP guidelines, or for response to a drug. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the aggregate classification.
Stars represent the aggregate review status, or the level of review supporting the aggregate germline classification for this VCV record. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. The number of submissions which contribute to this review status is shown in parentheses.
Uncertain significance(1); Benign(2); Likely benign(3)
No data submitted for somatic clinical impact
No data submitted for oncogenicity
Variant Details
- Identifiers
-
NM_032977.4(CASP10):c.1216A>T (p.Ile406Leu)
Variation ID: 333435 Accession: VCV000333435.31
- Type and length
-
single nucleotide variant, 1 bp
- Location
-
Cytogenetic: 2q33.1 2: 201209363 (GRCh38) [ NCBI UCSC ] 2: 202074086 (GRCh37) [ NCBI UCSC ]
- Timeline in ClinVar
-
First in ClinVar Help The date this variant first appeared in ClinVar with each type of classification.
Last submission Help The date of the most recent submission for each type of classification for this variant.
Last evaluated Help The most recent date that a submitter evaluated this variant for each type of classification.
Germline Dec 6, 2016 Oct 20, 2024 Mar 1, 2024 - HGVS
-
Nucleotide Protein Molecular
consequenceNM_032977.4:c.1216A>T MANE Select Help Transcripts from the Matched Annotation from the NCBI and EMBL-EBI (MANE) collaboration.
NP_116759.2:p.Ile406Leu missense NM_001206524.2:c.1015A>T NP_001193453.1:p.Ile339Leu missense NM_001206542.2:c.1087A>T NP_001193471.1:p.Ile363Leu missense NM_001230.5:c.1087A>T NP_001221.2:p.Ile363Leu missense NM_032974.5:c.1216A>T NP_116756.2:p.Ile406Leu missense NM_032976.4:c.*302A>T 3 prime UTR NC_000002.12:g.201209363A>T NC_000002.11:g.202074086A>T NG_007265.1:g.31232A>T LRG_33:g.31232A>T LRG_33t1:c.1216A>T LRG_33p1:p.Ile406Leu Q92851:p.Ile406Leu - Protein change
- I406L, I363L, I339L
- Other names
- -
- Canonical SPDI
- NC_000002.12:201209362:A:T
-
Functional
consequence HelpThe effect of the variant on RNA or protein function, based on experimental evidence from submitters.
- -
-
Global minor allele
frequency (GMAF) HelpThe global minor allele frequency calculated by the 1000 Genomes Project. The minor allele at this location is indicated in parentheses and may be different from the allele represented by this VCV record.
-
0.00479 (T)
-
Allele frequency
Help
The frequency of the allele represented by this VCV record.
-
Trans-Omics for Precision Medicine (TOPMed) 0.00232
The Genome Aggregation Database (gnomAD) 0.00307
The Genome Aggregation Database (gnomAD), exomes 0.00453
1000 Genomes Project 0.00479
1000 Genomes Project 30x 0.00484
Exome Aggregation Consortium (ExAC) 0.00494
- Links
Genes
Gene | OMIM | ClinGen Gene Dosage Sensitivity Curation |
Variation Viewer
Help
Links to Variation Viewer, a genome browser to view variation data from NCBI databases. |
Related variants | ||
---|---|---|---|---|---|---|
HI score
Help
The haploinsufficiency score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
TS score
Help
The triplosensitivity score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
Within gene
Help
The number of variants in ClinVar that are contained within this gene, with a link to view the list of variants. |
All
Help
The number of variants in ClinVar for this gene, including smaller variants within the gene and larger CNVs that overlap or fully contain the gene. |
|||
CASP10 | Little evidence for dosage pathogenicity | No evidence available |
GRCh38 GRCh37 |
520 | 554 |
Conditions - Germline
Condition
Help
The condition for this variant-condition (RCV) record in ClinVar. |
Classification
Help
The aggregate germline classification for this variant-condition (RCV) record in ClinVar. The number of submissions that contribute to this aggregate classification is shown in parentheses. (# of submissions) |
Review status
Help
The aggregate review status for this variant-condition (RCV) record in ClinVar. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. |
Last evaluated
Help
The most recent date that a submitter evaluated this variant for the condition. |
Variation/condition record
Help
The RCV accession number, with most recent version number, for the variant-condition record, with a link to the RCV web page. |
---|---|---|---|---|
Likely benign (3) |
criteria provided, multiple submitters, no conflicts
|
Jan 26, 2024 | RCV000378446.21 | |
Benign (1) |
criteria provided, single submitter
|
- | RCV001258256.10 | |
Conflicting interpretations of pathogenicity (3) |
criteria provided, conflicting classifications
|
Mar 1, 2024 | RCV000440171.25 |
Submissions - Germline
Classification
Help
The submitted germline classification for each SCV record. (Last evaluated) |
Review status
Help
Stars represent the review status, or the level of review supporting the submitted (SCV) record. This value is calculated by NCBI based on data from the submitter. Read our rules for calculating the review status. This column also includes a link to the submitter’s assertion criteria if provided, and the collection method. (Assertion criteria) |
Condition
Help
The condition for the classification, provided by the submitter for this submitted (SCV) record. This column also includes the affected status and allele origin of individuals observed with this variant. |
Submitter
Help
The submitting organization for this submitted (SCV) record. This column also includes the SCV accession and version number, the date this SCV first appeared in ClinVar, and the date that this SCV was last updated in ClinVar. |
More information
Help
This column includes more information supporting the classification, including citations, the comment on classification, and detailed evidence provided as observations of the variant by the submitter. |
|
---|---|---|---|---|---|
Likely benign
(Apr 27, 2017)
|
criteria provided, single submitter
Method: clinical testing
|
Autoimmune lymphoproliferative syndrome type 2A
Affected status: unknown
Allele origin:
germline
|
Illumina Laboratory Services, Illumina
Accession: SCV000426105.3
First in ClinVar: Dec 06, 2016 Last updated: May 31, 2020 |
Comment:
This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, … (more)
This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. (less)
|
|
Likely Benign
(Jan 06, 2017)
|
criteria provided, single submitter
Method: clinical testing
|
not provided
Affected status: not provided
Allele origin:
germline
|
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Accession: SCV000511682.1
First in ClinVar: Mar 08, 2017 Last updated: Mar 08, 2017 |
Comment:
Converted during submission to Likely benign.
|
|
Benign
(-)
|
criteria provided, single submitter
Method: research
|
Hypomyelination and Congenital Cataract
(Autosomal dominant inheritance)
Affected status: yes
Allele origin:
germline
|
Broad Center for Mendelian Genomics, Broad Institute of MIT and Harvard
Accession: SCV001435170.1
First in ClinVar: Oct 03, 2020 Last updated: Oct 03, 2020 |
Comment:
The heterozygous p.Ile406Leu variant in CASP10 has been identified in 2 individuals with autoimmune lymphoproliferative syndrome (PMID: 16446975), but has also been identified in >1% … (more)
The heterozygous p.Ile406Leu variant in CASP10 has been identified in 2 individuals with autoimmune lymphoproliferative syndrome (PMID: 16446975), but has also been identified in >1% of South Asian chromosomes and 9 homozygotes by ExAC (http://gnomad.broadinstitute.org/). This variant has also been identified in a heterozygous individual and a homozygous individual who have not been reported to have disease (PMID: 22995991). In vitro functional studies provide some evidence that the p.Ile406Leu variant may slightly impact protein function (PMID: 16446975). However, these types of assays may not accurately represent biological function. In summary, this variant meets criteria to be classified as benign for autosomal dominant autoimmune lymphoproliferative syndrome. (less)
|
|
Likely benign
(Jan 26, 2024)
|
criteria provided, single submitter
Method: clinical testing
|
Autoimmune lymphoproliferative syndrome type 2A
Autoimmune lymphoproliferative syndrome type 2A
Explanation for multiple conditions: Uncertain.
The variant was classified for several related diseases, possibly a spectrum of disease; the variant may be associated with one or more the diseases.
Affected status: unknown
Allele origin:
germline
|
Labcorp Genetics (formerly Invitae), Labcorp
Accession: SCV000644013.9
First in ClinVar: Dec 26, 2017 Last updated: Feb 28, 2024 |
|
|
Uncertain significance
(Mar 08, 2022)
|
criteria provided, single submitter
Method: clinical testing
|
Not Provided
Affected status: yes
Allele origin:
germline
|
GeneDx
Accession: SCV002107205.2
First in ClinVar: Mar 28, 2022 Last updated: Mar 04, 2023 |
Comment:
Published in vitro functional studies showed that this variant conferred significant resistance to apoptosis in transfected cells which was even stronger when co-transfected with wild-type … (more)
Published in vitro functional studies showed that this variant conferred significant resistance to apoptosis in transfected cells which was even stronger when co-transfected with wild-type CASP10 indicating a probable dominant negative effect (Zhu et al., 2006); This variant is associated with the following publications: (PMID: 22995991, 27535533, 16446975, 32599613, 27378136, 31309545) (less)
|
|
Benign
(Mar 01, 2024)
|
criteria provided, single submitter
Method: clinical testing
|
not provided
Affected status: yes
Allele origin:
germline
|
CeGaT Center for Human Genetics Tuebingen
Accession: SCV004011287.12
First in ClinVar: Jul 16, 2023 Last updated: Oct 20, 2024 |
Comment:
CASP10: BP4, BS1, BS2
Number of individuals with the variant: 7
|
|
not provided
(-)
|
no classification provided
Method: literature only
|
Autoimmune lymphoproliferative syndrome type 2A
Affected status: unknown
Allele origin:
germline
|
GeneReviews
Accession: SCV002032180.2
First in ClinVar: Dec 14, 2021 Last updated: Oct 01, 2022 |
|
Germline Functional Evidence
There is no functional evidence in ClinVar for this variation. If you have generated functional data for this variation, please consider submitting that data to ClinVar. |
Citations for germline classification of this variant
HelpTitle | Author | Journal | Year | Link |
---|---|---|---|---|
Autoimmune Lymphoproliferative Syndrome. | Adam MP | - | 2017 | PMID: 20301287 |
An informatics approach to analyzing the incidentalome. | Berg JS | Genetics in medicine : official journal of the American College of Medical Genetics | 2013 | PMID: 22995991 |
Genetic alterations in caspase-10 may be causative or protective in autoimmune lymphoproliferative syndrome. | Zhu S | Human genetics | 2006 | PMID: 16446975 |
Text-mined citations for rs80358239 ...
HelpRecord last updated Nov 10, 2024
This date represents the last time this VCV record was updated. The update may be due to an update to one of the included submitted records (SCVs), or due to an update that ClinVar made to the variant such as adding HGVS expressions or a rs number. So this date may be different from the date of the “most recent submission” reported at the top of this page.